Jun Wu
15Patents
2h-index
68Co-inventors
53Inventor score
Filing activity: Apr 9, 2003 → Oct 30, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10035804B2 | Spirodiamine derivatives as aldosterone synthase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US7626016B2 | Process for preparing sucrose-6-ester | Chemistry; Metallurgy | 3 | Active |
| US10844098B2 | Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein | Chemistry; Metallurgy | 2 | Active |
| US9505742B2 | 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds | Chemistry; Metallurgy | 1 | Active |
| US6800590B2 | 2-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses | Chemistry; Metallurgy | 1 | Expired |
| US11767427B2 | Polycarbonate alloy and preparation method thereof and application | Chemistry; Metallurgy | 0 | Active |
| US9796726B2 | Dihydroquinoline pyrazolyl compounds | Human Necessities | 0 | Active |
| US12227545B2 | Acinetobacter baumannii immunogenic protein and composition and application thereof | Chemistry; Metallurgy | 0 | Active |
| US10709777B2 | Salmonella paratyphi A with an O-antigen having an extended carbohydrate chain and use thereof | General | 0 | Revoked |
| US10780154B2 | Salmonella paratyphi A with an O-antigen having an extended carbohydrate chain and use thereof | Human Necessities | 0 | Active |
| US11993591B2 | Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease | Chemistry; Metallurgy | 0 | Active |
| US12012390B2 | Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease | Chemistry; Metallurgy | 0 | Active |
| US12129376B2 | Antibacterial polycarbonate composite and preparation method thereof | Chemistry; Metallurgy | 0 | Active |
| US9796702B2 | Dihydroquinoline pyrazolyl compounds | Human Necessities | 0 | Active |
| US9790217B2 | Pyridinyloxy- and phenyloxy-pyrazolyl compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.